Health

India’s COVID-19 recoveries have crossed 56 lakhs, with a recovery rate exceeding 84%. More than 8 crore COVID tests have been conducted so far, of which 80 lakh tests were done in the last week. This has been briefed by Union Secretary, Ministry of Health and Family Welfare, Shri Rajesh Bhushan in a media briefing on latest updates, preparedness and actions taken on COVID-19, at the National Media Centre in New Delhi today.

After 13 years of research, India’s first personalized medicine for Duchenne muscular dystrophy (DMD) has received the green signal from the Drug Controller General of India (DCGI), paving the way for clinical trials.

India has crossed a landmark milestone. The active cases has been maintained the below the 10 lakh mark for 14 days unabated.

It was only four years ago when Veeralakshmi approached ANEW, a women’s welfare association in Anna Nagar, for work. “They were providing vocational training for women and helping them get jobs. I enrolled myself into their driving course. Since I had the experience of watching my husband drive, I was confident that I could do this,” she says.

India continues to report high number of recoveries. The recovered cases have exceeded the new confirmed again during the past 24 hours. With this, India’s Recovery Rate has leaped past 83% today.

The government-run KEM Hospital here on Saturday will administer, as part of human trial, Oxford University’s Covishield vaccine for coronavirus to three persons, said hospital Dean Dr Hemant Deshmukh.
“We have screened 13 persons so far including 10 today, of which three will get the first shot of Oxford University-AstraZeneca developed Covishield vaccine on Saturday,” he said.